Amgen Inc's Fiscal Year is From January To December - All Figures are in Billions.
The item "Diluted-Average-Shares" stands at 2.17 Billion for the trailing twelve months (TTM) period ending 09/30/2025, the highest value since 12/31/2022.
Amgen Inc's third quarter result of 0.542 Billion for the item "Diluted Average Shares" represents an increase of 0.18 percent compared to it's second quarter result.
Also, Amgen Inc's third quarter result of 0.542 Billion for the item "Diluted Average Shares" represents no change compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), Amgen Inc's third quarter result of 2.17 Billion for the item "Diluted Average Shares" represents no change compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 0.3242 percent compared to the value the year prior.
The 1 year change in percent is 0.3242.
The 3 year change in percent is -1.14.
The 5 year change in percent is -8.72.
The 10 year change in percent is -29.54.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Diluted Average Shares | 905,699,262,464.00 |
![]() | Johnson & Johnson - Diluted Average Shares | 486,508,953,600.00 |
![]() | AbbVie Inc - Diluted Average Shares | 399,570,305,024.00 |
![]() | Roche Holding AG - Diluted Average Shares | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Diluted Average Shares | 280,205,508,085.11 |